Infusion of Bispecific Monoclonal Antibody Complexes into Monkeys Provides Immunologic Protection against Later Challenge with a Model Pathogen
- 31 August 1999
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 92 (2) , 170-180
- https://doi.org/10.1006/clim.1999.4739
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Complement Receptor 2 in the Regulation of the Immune ResponseClinical Immunology and Immunopathology, 1998
- Controlling the complement system in inflammationImmunopharmacology, 1997
- Primate Erythrocyte (E) Complement Receptor (CR1) as an Anchor Site for Bispecific-Based Therapies to Clear Pathogens or Autoantibodies Safely from the CirculationJournal of Hematotherapy, 1995
- Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.Proceedings of the National Academy of Sciences, 1991
- Physiological and pathological aspects of circulating immune complexesKidney International, 1989
- Complement in the Pathophysiology of Human DiseaseNew England Journal of Medicine, 1987
- The erythrocyte–immune complex–glomerulonephritis connection in manKidney International, 1987
- Primate erythrocyte-immune complex-clearing mechanism.Journal of Clinical Investigation, 1983
- Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteThe Journal of Experimental Medicine, 1980
- The Immune-Adherence PhenomenonScience, 1953